FDA Safety Review of Mifepristone Continues Into 2027
The FDA says its mifepristone safety review will continue into 2027, with a study expected to finish by mid-December and a report due no later than March. The agency says…
The FDA says its mifepristone safety review will continue into 2027, with a study expected to finish by mid-December and a report due no later than March. The agency says…